[ad_1]
Ursula von der Leyen appears secure in her job as president of the European Commission.
That’s despite a troubled vaccine rollout in which delayed deliveries can cost lives and livelihoods.
But preserving the status quo in Brussels also comes at a cost. Mehreen Khan of the Financial Times unpacks why the European institutions are not much interested in asking what’s gone wrong – let alone in taking the scalp of von der Leyen. Hans Kundnani of Chatham House warns that unaddressed vaccine mishaps in Brussels – and simmering tensions over how to disburse pandemic relief funds – are storing up new troubles for the European project.
[ad_2]
Source link